Pages that link to "Q83364115"
Jump to navigation
Jump to search
The following pages link to Correlation between plasma levels of glutamate, alanine and serine with severity of depression (Q83364115):
Displaying 50 items.
- Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders (Q24632936) (← links)
- Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date (Q27004490) (← links)
- Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice (Q28485938) (← links)
- Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift (Q30906677) (← links)
- Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems (Q33635613) (← links)
- Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder (Q33678466) (← links)
- The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis (Q33679513) (← links)
- Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed mice (Q33814381) (← links)
- Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder. (Q33838237) (← links)
- The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain (Q33863747) (← links)
- Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder (Q33884852) (← links)
- Serum glutamine, set-shifting ability and anorexia nervosa (Q33986685) (← links)
- Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics (Q34555598) (← links)
- Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder (Q34588846) (← links)
- Optimization and validation of a capillary electrophoresis laser-induced fluorescence method for amino acids determination in human plasma: application to bipolar disorder study (Q34628120) (← links)
- Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder (Q34965754) (← links)
- Ketamine and the next generation of antidepressants with a rapid onset of action (Q34978041) (← links)
- An excitatory synapse hypothesis of depression (Q35563515) (← links)
- Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice. (Q35713544) (← links)
- AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder (Q35745279) (← links)
- Blood Glutamate Scavenging: Insight into Neuroprotection (Q36202424) (← links)
- Overview of Glutamatergic Dysregulation in Central Pathologies (Q36409596) (← links)
- Neurochemical alterations in frontal cortex of the rat after one week of hypobaric hypoxia (Q36424593) (← links)
- Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder (Q36540042) (← links)
- Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection (Q36648773) (← links)
- GABAergic control of depression-related brain states (Q36668325) (← links)
- Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice (Q36788384) (← links)
- The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects (Q37067679) (← links)
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders (Q37143117) (← links)
- The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders (Q37172873) (← links)
- Metabolic Signatures of Kidney Yang Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS (Q37212763) (← links)
- Discovery, screening and evaluation of a plasma biomarker panel for subjects with psychological suboptimal health state using (1)H-NMR-based metabolomics profiles (Q37271758) (← links)
- The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders (Q37387700) (← links)
- Neuroinflammation and comorbidity of pain and depression (Q37432089) (← links)
- Depression and antidepressants: molecular and cellular aspects. (Q37517285) (← links)
- Ketamine as antidepressant? Current state and future perspectives (Q37559823) (← links)
- Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence (Q37604161) (← links)
- Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression. (Q37605157) (← links)
- Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? (Q38047583) (← links)
- Glutamate system as target for development of novel antidepressants (Q38078152) (← links)
- Is depression associated with an increased risk of treatment-resistant epilepsy? Research strategies to investigate this question (Q38254682) (← links)
- The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review (Q38861612) (← links)
- Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility (Q39268200) (← links)
- Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus. (Q39285698) (← links)
- Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review (Q39427752) (← links)
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial (Q39557334) (← links)
- Resting Glutamate Levels and Rapid Glutamate Transients in the Prefrontal Cortex of the Flinders Sensitive Line Rat: A Genetic Rodent Model of Depression (Q39756450) (← links)
- Metabotropic glutamate receptors: potential drug targets for psychiatric disorders (Q41157725) (← links)
- Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression (Q41430366) (← links)
- Simultaneous Determination of Glutamate, Glycine, and Alanine in Human Plasma Using Precolumn Derivatization with 6-Aminoquinolyl-N-hydroxysuccinimidyl Carbamate and High-Performance Liquid Chromatography (Q41624703) (← links)